Equibles does not estimate personal net worth.
Steven Sherman was last confirmed as Board Member at ChronoScale Holdings Corp (CHRN) in a filing dated April 28, 2023. Steven Sherman was last confirmed as Chairman at ChronoScale Holdings Corp (CHRN) in a filing dated April 29, 2021. Earlier roles on record: CEO at ChronoScale Holdings Corp (CHRN) until December 4, 2022. ChronoScale Holdings Corp reported in an 8-K filed December 5, 2022 that Steven Sherman was appointed Executive Chair, effective December 5, 2022. ChronoScale Holdings Corp reported in an 8-K filed December 5, 2022 that Steven Sherman resigned as Chief Executive Officer, effective December 5, 2022. ChronoScale Holdings Corp reported in an 8-K filed December 5, 2022 that Steven Sherman resigned as Chief Executive Officer, effective December 4, 2022. The proxy statement of ChronoScale Holdings Corp reports total compensation of $777,926 for Steven Sherman in fiscal 2022, including a base salary of $481,858. Steven Sherman has spoken on 4 earnings calls across 1 company, most recently for ChronoScale Holdings Corp on November 3, 2022. The companies whose calls Steven Sherman spoke on are classified in the Technology sector.
“Mr. Sherman will continue to serve as Chairman of the Board and will begin serving as Executive Chair of the Company.”
“Mr. Sherman resigned as the Company's Chief Executive Officer, and the Ekso Bionics Board of Directors appointed Mr. Davis as Chief Executive Officer, each effective immediately.”
“We had strong execution this quarter in all our segments. We achieved a record number of quarterly EksoNR bookings, generated several multi-unit capital purchase orders from network operators, and booked new orders internationally in both Europe and Asia.”
“We achieved strong revenue growth in the second quarter, reflecting the continued execution by our team. We are successfully raising awareness of the benefits that our innovative EksoNR devices are bringing to patients.”
“Revenues in the first quarter were up by more than 30% year-over-year, and we are seeing momentum in both our EksoHealth and our EksoWorks business segments. Our customers recognize the value and benefits that wearable exoskeletons bring to both patients and essential workers.”
“And thank you everyone for joining us today. I am pleased to participate in my first conference call as Ekso Bionics' new Chief Executive Officer, and I will be working in tandem with our experienced leadership team.”
2022-01-22–2022-12-04
Start not stated–2021-04-29
Last confirmed by a filing; no departure on record
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
Start not stated–2022-12-04
Information Technology Services · Technology
Chairman, Board Member, CEO
2022-01-22–2022-12-04
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | ChronoScale Holdings Corp (CHRN) | Former Chief Executive Officer and Executive Chair | $481,858 | $777,926 |
